Analyzing MYnd Analytics (MYND) and Davita (DVA)
MYnd Analytics (NASDAQ:MYND) and Davita (NYSE:DVA) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.
This table compares MYnd Analytics and Davita’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
MYnd Analytics has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500. Comparatively, Davita has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.
This is a summary of current recommendations for MYnd Analytics and Davita, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
MYnd Analytics presently has a consensus price target of $5.00, indicating a potential upside of 240.14%. Davita has a consensus price target of $85.29, indicating a potential upside of 22.36%. Given MYnd Analytics’ stronger consensus rating and higher possible upside, analysts clearly believe MYnd Analytics is more favorable than Davita.
Valuation & Earnings
This table compares MYnd Analytics and Davita’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|MYnd Analytics||$130,000.00||85.37||-$7.11 million||N/A||N/A|
|Davita||$10.88 billion||1.07||$663.61 million||$3.32||20.99|
Davita has higher revenue and earnings than MYnd Analytics.
Institutional and Insider Ownership
1.5% of MYnd Analytics shares are held by institutional investors. Comparatively, 87.4% of Davita shares are held by institutional investors. 23.4% of MYnd Analytics shares are held by insiders. Comparatively, 1.0% of Davita shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Davita beats MYnd Analytics on 8 of the 12 factors compared between the two stocks.
MYnd Analytics Company Profile
MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States. The company offers objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. It uses its proprietary neurometric platform, PEER Online, to generate Psychiatric electroencephalogram (EEG) Evaluation Registry (PEER) reports to predict the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders. The company also manages the delivery of telepsychiatry and telebehavioral health services through a network of psychiatrists, psychologists, and therapists. The company was formerly known as CNS Response, Inc. and changed its name to MYnd Analytics, Inc. in November 2015. MYnd Analytics, Inc. was founded in 2000 and is headquartered in Mission Viejo, California.
Davita Company Profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications and medication management services to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2017, it provided dialysis and administrative services in the United States through a network of 2,510 outpatient dialysis centers serving approximately 197,800 patients; and operated 237 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.